A. Konur et al., CYTOKINE REPERTOIRE DURING MATURATION OF MONOCYTES TO MACROPHAGES WITHIN SPHEROIDS OF MALIGNANT AND NONMALIGNANT UROTHELIAL CELL-LINES, International journal of cancer, 78(5), 1998, pp. 648-653
Terminal maturation of human blood monocytes to macrophages (MAC) in v
ivo is believed to be important for the morphology, antigen expression
and functional activity of the resulting MAC population. This process
is modulated by the specific tissue micro-environment to which blood
monocytes migrate upon leaving the vasculature. Tumor-associated macro
phages (TAM) are a special type of NAG, and little is known about the
modulating capacity of the tumor environment on monocyte-to-MAC differ
entiation. By co-culturing 8-dimensional multicellular spheroids (MCS)
of the urothelial-bladder-carcinoma cell fines J82 and RT4 with human
monocytes/MAC we generated TAM in vitro. For comparison, monocytes/MA
C were co-cultured with the non-tumorigenic urothelial cell line HCV29
. The effects on monocyte differentiation were analyzed, particularly
with respect to cytokine release. Monocyte maturation was modulated wi
thin the tumor spheroid dependent upon the tumor cell type. Monocytes
co-cultured with MCS of the poorly differentiated J82 carcinoma sponta
neously produced high amounts of IL-IP and IL-6, but only low amounts
of TNF-alpha, which could be Further increased by the addition of LPS.
This cytokine pattern is characteristic for monocytes and remained co
nstant for up to 8 days in J82-MCS co-cultures, However; in RT4-MCS an
d HCV29-MCS co-cultures, the initial cytokine pattern changed and afte
r 8 days corresponded well to that of MAC differentiated in vitro with
out tumor contact. In addition to functional parameters, we analyzed t
he morphology of J82-MCS-TAM and found that they displayed a monocytel
ike morphology. Our data indicate that (1) tumor cells can influence m
onocyte-to-MAC differentiation, giving rise to TAM with monocyte-speci
fic phenotypic properties; and (2) this capacity is dependent on the t
ype of tumor cell. (C) 1998 Wiley-Liss, Inc.